MFDS — authorised 17 September 1998
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇰🇷 Sustiva in South Korea
MFDS authorised Sustiva on 17 September 1998
Marketing authorisation
Sustiva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Sustiva approved in South Korea?
Yes. MFDS authorised it on 17 September 1998.
Who is the marketing authorisation holder for Sustiva in South Korea?
BRISTOL MYERS SQUIBB holds the South Korean marketing authorisation.